Trending Now
Actuate Therapeutics Recently Issued an Update on Its Phase Two Study...
Actuate Therapeutics recently executed a partnership with the University of Kansas Cancer Center to research and develop the elraglusib Drug. The partnership focuses on...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Appoint Industry Veteran; AEterna Zentaris Inc....
The press release to the investor by the pharmaceutical companies reveals two distinct things. On the one hand, BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Appoint...
MAKE IT MODERN
LATEST REVIEWS
Sorrento Therapeutics Inc (NASDAQ: SRNE) Recently Issued an Update of Its...
Sorrento Therapeutics Inc (NASDAQ: SRNE) recently updated its recent study to its shareholders. The company announced that it recruited fit volunteers. Moreover, the study...
MAKE IT MODERN
PERFORMANCE TRAINING
Time to Revisit Previously Booming CBD Space for Big Growth on Sale (YCBD, TLRY,...
The key to investing is “Buy low, sell high”. According to that mantra, periods of weakness are the mother’s milk of future...
MediciNova Inc. (NASDAQ:MNOV) Reports Promising Results Of Its Intranasal BC-PIV SARS-CoV-2 Vaccine Candidate
MediciNova Inc. (NASDAQ:MNOV) announced that its intranasal COVID-19 vaccine candidate that is employing the BC-PIV tech, induced systemic serum IgG as well as mucosal...
Mustang Bio Inc. (NASDAQ:MBIO) Commences Dosing Of Patients With MB-102 And Enters Agreement With...
Mustang Bio Inc. (NASDAQ:MBIO) has announced the dosing of the first patient in its multicentre, Open-label phase 1/2 study evaluating efficacy and safety of...
SPY puts are still Wall Street’s favorite
Futures are up a bit this morning but have yo yoed all morning. The SPY is currently sitting at 314.22 in the...
Cue Biopharma Inc (NASDAQ:CUE) Advances CUE-101 Dose Escalation Phase 1 Monotherapy Clinical Trial
Cue Biopharma Inc (NASDAQ:CUE) received encouraging results in the cohort 5 and cohort 4 dosing and got clearance from the SRC (Safety Review Committee)....
MAKE IT MODERN
